- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT07691112
Prevalence of Chapman Reflex Points in Medical Students and Their Association With Visceral Symptoms
Chapman Reflex Points (CRPs) are small palpable nodules found within connective tissue that have traditionally been associated with dysfunction of internal organs and the autonomic nervous system. However, little is known about how commonly these findings occur in healthy individuals or whether they are associated with symptoms experienced by otherwise healthy people.
The purpose of this study is to determine the prevalence of Chapman Reflex Points in young healthy adults and to evaluate whether the presence and distribution of these points are associated with self-reported visceral symptoms. Participants complete a standardized health questionnaire regarding recent and recurrent symptoms and undergo a blinded physical examination of established Chapman Reflex Point locations performed by a trained investigator. The results of this study may improve understanding of the physiological mechanisms underlying Chapman Reflex Points and help clarify their potential role in preventive osteopathic assessment and early identification of altered autonomic, lymphatic, fascial, or neuroendocrine function.
Tutkimuksen yleiskatsaus
Tila
Ehdot
Interventio / Hoito
Yksityiskohtainen kuvaus
Chapman Reflex Points (CRPs) are discrete palpable nodules located within deep fascial tissues that have historically been interpreted as viscerosomatic reflex manifestations associated with dysfunction of specific internal organs. Traditional osteopathic models suggest that CRPs develop secondary to altered autonomic activity and lymphatic dysfunction resulting from visceral pathology. More recent mechanobiological investigations have proposed that fascial contractility mediated by myofibroblasts, sympathetic regulation of lymphatic vessel function, connective tissue remodeling, and neuroendocrine influences may contribute to the formation and persistence of these palpable findings.
Despite their longstanding use in osteopathic diagnosis and treatment, there is limited evidence regarding the prevalence of CRPs in healthy individuals, and relatively few studies have investigated whether the presence of CRPs correlates with self-reported visceral symptoms in populations without significant underlying disease. Improved characterization of CRP prevalence and symptom associations may provide insight into whether these findings represent markers of overt pathology, subclinical physiological modulation, or normal biological variation.
This study was designed as a cross-sectional observational investigation to evaluate the prevalence and distribution of CRPs in a young adult population and to explore potential relationships between CRP findings and participant-reported visceral symptoms. Participants completed a standardized health questionnaire designed to assess demographic characteristics, medical history, lifestyle factors, and recent or recurrent symptoms across multiple organ systems. Following questionnaire completion, participants underwent a systematic palpatory examination of established Chapman Reflex Point locations performed by a single trained investigator who was blinded to questionnaire responses. Consistent palpatory techniques, including standardized pressure application and examination duration, were utilized to improve examination reproducibility.
Participant data were recorded using anonymized study identification numbers to maintain confidentiality. Statistical analyses were performed using Microsoft Excel and STATA software. Descriptive statistics were used to characterize participant demographics and CRP prevalence. Sex-based differences in total CRP counts were evaluated using Welch's two-sample t-test. Associations between individual Chapman Reflex Points and symptom clusters were assessed using stepwise regression analyses, while relationships between grouped CRPs and grouped visceral symptom scores were examined using bivariate linear regression techniques. Statistical significance was defined as a two-sided p-value of less than 0.05.
The findings from this study are intended to contribute to a contemporary understanding of Chapman Reflex Point physiology by integrating concepts related to autonomic regulation, lymphatic function, fascial mechanotransduction, and endocrine modulation. Further investigation may help clarify the potential utility of CRPs as markers of early physiological alterations and inform their role in preventive osteopathic assessment and individualized patient evaluation.
Opintotyyppi
Ilmoittautuminen (Todellinen)
Yhteystiedot ja paikat
Opiskelupaikat
-
-
New York
-
New York, New York, Yhdysvallat, 10027
- Touro College of Osteopathic Medicine - Harlem
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
- Aikuinen
- Vanhempi Aikuinen
Hyväksyy terveitä vapaaehtoisia
Näytteenottomenetelmä
Tutkimusväestö
Kuvaus
Inclusion Criteria:
- Adults aged 18 years or older.
- Ability to understand the study procedures and provide informed consent.
- Willingness to complete a standardized health questionnaire.
- Willingness to undergo a blinded palpatory examination of established Chapman Reflex Point locations.
Exclusion Criteria:
- Individuals younger than 18 years of age.
- Inability or unwillingness to provide informed consent.
- Inability or unwillingness to complete the health questionnaire.
- Inability or unwillingness to undergo the palpatory examination.
- Pregnancy.
- Incomplete study data or questionnaire responses.
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
Kohortit ja interventiot
Ryhmä/Kohortti |
Interventio / Hoito |
|---|---|
|
Healthy Young Adults
Participants were young adults who completed a standardized health questionnaire assessing demographic characteristics, medical history, lifestyle factors, and recent or recurrent visceral symptoms.
Participants subsequently underwent a blinded palpatory examination of established Chapman Reflex Point locations performed by a trained investigator.
No therapeutic intervention was administered.
The study evaluated the prevalence and distribution of Chapman Reflex Points and their associations with self-reported visceral symptom clusters.
|
Participants underwent a standardized palpatory examination of established Chapman Reflex Point locations performed by a single trained investigator who was blinded to questionnaire responses.
Consistent pressure application and examination duration were utilized to optimize reliability and reproducibility of palpatory findings.
No therapeutic intervention, osteopathic manipulative treatment, medication administration, or other clinical intervention was provided as part of the study.
Participants also completed a standardized health questionnaire assessing demographic characteristics, medical history, lifestyle factors, and recent or recurrent visceral symptoms.
Muut nimet:
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Prevalence of Chapman Reflex Points
Aikaikkuna: through study completion, an average of 1 year
|
The prevalence and distribution of Chapman Reflex Points identified during a standardized palpatory examination of established Chapman Reflex Point locations performed by a blinded trained investigator.
The total number of Chapman Reflex Points observed per participant was recorded and summarized using descriptive statistics.
|
through study completion, an average of 1 year
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Association Between Chapman Reflex Points and Visceral Symptom Clusters
Aikaikkuna: through study completion, an average of 1 year
|
Associations between organ system-specific Chapman Reflex Point counts and self-reported visceral symptom clusters were evaluated using stepwise regression analyses and bivariate linear regression models.
|
through study completion, an average of 1 year
|
|
Sex Differences in Chapman Reflex Point Prevalence
Aikaikkuna: through study completion, an average of 1 year
|
Differences in the total number of Chapman Reflex Points identified among male and female participants were assessed using Welch's two-sample t-test.
|
through study completion, an average of 1 year
|
Muut tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Distribution of Organ System-Specific Chapman Reflex Points
Aikaikkuna: through study completion, an average of 1 year
|
The frequency of Chapman Reflex Points corresponding to individual organ systems, including pulmonary and lower gastrointestinal groupings, was assessed descriptively.
|
through study completion, an average of 1 year
|
Yhteistyökumppanit ja tutkijat
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Todellinen)
Opintojen valmistuminen (Todellinen)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
- Autonominen hermosto
- Kojelauta
- Sympaattinen hermosto
- Osteopaattinen lääketiede
- Ehkäisevä lääke
- Lymfaattinen järjestelmä
- Osteopaattinen manipuloiva lääketiede
- Sidekudos
- Myofibroblastit
- Somaattinen toimintahäiriö
- Chapman Reflex Points
- Chapman Reflexes
- Viscerosomatic Reflexes
- Fascial Tissue
- Lymphatic Physiology
- Neuroendocrine Regulation
- Mechanotransduction
- Palpatory Examination
- Visceral Symptoms
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- HSIRB_2019
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .